Melanotan II research in Canada investigates the melanocortin receptor pharmacology of this synthetic cyclic heptapeptide. Melanotan II (MT-II) is an analogue of α-MSH that non-selectively activates melanocortin receptors MC1R, MC3R, MC4R, and MC5R. Canadian dermatology and metabolic researchers study MT-II for its effects on melanogenesis (skin pigmentation biology), appetite suppression, and energy homeostasis mediated through these receptor subtypes.
Melanocortin Receptor Biology Research
Melanocortin receptors mediate a remarkably diverse range of biological functions. MC1R regulates skin pigmentation and UV protection in melanocytes. MC4R is expressed in the hypothalamus and regulates energy balance and satiety signalling. MC3R modulates inflammatory responses. Canadian pharmacology researchers study MT-II as a broad-spectrum melanocortin agonist tool for investigating receptor subtype contributions to each of these biological processes.
Melanogenesis Research
MT-II activates MC1R on melanocytes to stimulate melanin synthesis and melanosome transfer to keratinocytes. Canadian dermatology researchers use MT-II to study the MC1R signalling cascade, cAMP production, and MITF (melanocyte inducing transcription factor) activation that drives melanin production in cell culture models.
Sourcing Melanotan II in Canada
Research-grade Melanotan II is available in Canada from EhBuddy Peptides. Lab-tested for purity. For laboratory research use only.
Melanotan II is a versatile melanocortin receptor research tool in Canada for scientists studying skin pigmentation biology, energy balance, and melanocortin receptor pharmacology across multiple receptor subtypes.
